Intervacc (Sweden) Performance
| IVACC Stock | SEK 2.60 0.06 2.36% |
The company retains a Market Volatility (i.e., Beta) of -0.42, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Intervacc are expected to decrease at a much lower rate. During the bear market, Intervacc is likely to outperform the market. At this point, Intervacc AB has a negative expected return of -0.56%. Please make sure to check out Intervacc's daily balance of power, market facilitation index, and the relationship between the kurtosis and day median price , to decide if Intervacc AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Intervacc AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 164.3 M | |
| Total Cashflows From Investing Activities | -23.1 M |
Intervacc |
Intervacc Relative Risk vs. Return Landscape
If you would invest 404.00 in Intervacc AB on August 25, 2024 and sell it today you would lose (144.00) from holding Intervacc AB or give up 35.64% of portfolio value over 90 days. Intervacc AB is generating negative expected returns and assumes 4.7318% volatility on return distribution over the 90 days horizon. Simply put, 42% of stocks are less volatile than Intervacc, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Intervacc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Intervacc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Intervacc AB, and traders can use it to determine the average amount a Intervacc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1178
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IVACC |
Estimated Market Risk
| 4.73 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.56 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Intervacc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intervacc by adding Intervacc to a well-diversified portfolio.
Intervacc Fundamentals Growth
Intervacc Stock prices reflect investors' perceptions of the future prospects and financial health of Intervacc, and Intervacc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Intervacc Stock performance.
| Return On Equity | -0.17 | |||
| Return On Asset | -0.0991 | |||
| Operating Margin | (4.77) % | |||
| Current Valuation | 1.26 B | |||
| Shares Outstanding | 50.49 M | |||
| Price To Book | 5.02 X | |||
| Price To Sales | 125.83 X | |||
| Revenue | 5.24 M | |||
| EBITDA | (23.15 M) | |||
| Cash And Equivalents | 148.98 M | |||
| Cash Per Share | 2.97 X | |||
| Total Debt | 222 K | |||
| Book Value Per Share | 5.41 X | |||
| Cash Flow From Operations | (25.46 M) | |||
| Earnings Per Share | (0.67) X | |||
| Total Asset | 329.39 M | |||
About Intervacc Performance
Assessing Intervacc's fundamental ratios provides investors with valuable insights into Intervacc's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Intervacc is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Intervacc AB , a biotechnology company, engages in the research and development of veterinary vaccines using recombinant proteins for animal health. The company has a collaboration with the Karolinska Institute. Intervacc operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.Things to note about Intervacc AB performance evaluation
Checking the ongoing alerts about Intervacc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Intervacc AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Intervacc AB generated a negative expected return over the last 90 days | |
| Intervacc AB has high historical volatility and very poor performance | |
| Intervacc AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.24 M. Net Loss for the year was (29.38 M) with profit before overhead, payroll, taxes, and interest of 6.25 M. | |
| Intervacc AB has accumulated about 148.98 M in cash with (25.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 14.0% of the company shares are held by company insiders |
- Analyzing Intervacc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Intervacc's stock is overvalued or undervalued compared to its peers.
- Examining Intervacc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Intervacc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Intervacc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Intervacc's stock. These opinions can provide insight into Intervacc's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Intervacc Stock Analysis
When running Intervacc's price analysis, check to measure Intervacc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intervacc is operating at the current time. Most of Intervacc's value examination focuses on studying past and present price action to predict the probability of Intervacc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intervacc's price. Additionally, you may evaluate how the addition of Intervacc to your portfolios can decrease your overall portfolio volatility.